# Erythromycin Ethylsuccinate

NDC: 69238-1504
Generic name: Erythromycin
Labeler / Manufacturer: Amneal Pharmaceuticals NY LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20191104

FDA application: ANDA211204

## Active ingredients

- ERYTHROMYCIN ETHYLSUCCINATE: 400 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69238-1504"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69238-1504
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=596fa019-b0eb-4e57-93ff-195a765a2e91